I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Nanoparticle conjugation of ginsenoside Rb3 inhibits myocar..:
Yi Zhang
;
Haixia Ji
;
Ou Qiao
...
http://www.sciencedirect.com/science/article/pii/S0753332221004157. , 2021
Link:
https://doi.org/10.1016/j.biopha.2021.111630
RT Journal T1
Nanoparticle conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by regulating PPARα pathway
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:96f8bcc5617547ad89b9999168dbbe68&Exemplar=1&LAN=DE A1 Yi Zhang A1 Haixia Ji A1 Ou Qiao A1 Zhi Li A1 Lorenzo Pecoraro A1 Xueqian Zhang A1 Xiaoying Han A1 Wenzhe Wang A1 Xinyu Zhang A1 Shuli Man A1 Juan Wang A1 Xia Li A1 Changxiao Liu A1 Luqi Huang A1 Wenyuan Gao PB Elsevier YR 2021 K1 Nanoparticles conjugation with ginsenoside Rb3 (NpRb3) K1 Myocardial fibrosis K1 Energy metabolism K1 Perixisome proliferation-activated receptor alpha (PPARα) K1 Transforming growth factor beta 1 (TGF-β1) K1 Oral bioavailability enhancement K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S0753332221004157 LK http://dx.doi.org/https://doi.org/10.1016/j.biopha.2021.111630 DO https://doi.org/10.1016/j.biopha.2021.111630 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)